Evofem Biosciences EVFM
OTC EVFM
$0.01 +0.00 (+0.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

Evofem Biosciences (EVFM) Operating Margin (2020 - 2026)

Updated

Evofem Biosciences' Operating Margin came in at -94.53% for Q2 2026, down 68.60 percentage points from -25.93% a year earlier but up 413.70 percentage points from the prior quarter.

Analysis

Evofem Biosciences (EVFM) Operating Margin (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Evofem Biosciences reported Operating Margin of -15.31%, up 9.98 percentage points year-over-year; for FY2025, it came in at 16.71%, up 56.35 percentage points from FY2024.

  • Operating Margin has increased in each of the last five years, with a five-year change of +23250.79 percentage points (FY2020 to FY2025).
  • Going back by year, Operating Margin was -39.64% in FY2024 (+58.32 pp), -97.96% in FY2023 (+401.67 pp), -499.64% in FY2022 (+1523.66 pp) and -2023.30% in FY2021 (+21210.78 pp).
  • The five-year range for quarterly Operating Margin is -6658.56% (Q4 2022) to 38.70% (Q1 2025).
  • Year-over-year, Operating Margin increased in six of the last eight quarters, with an average year-over-year change of -37.11 percentage points.
  • The fastest year-over-year change in Operating Margin over five years came in Q4 2021 (a gain of 20291.76 percentage points), and the weakest in Q4 2022 (a drop of 5610.44 percentage points).
  • Business Quant data shows EVFM's Operating Margin at -508.23% (Q1 2026), 34.99% (Q4 2025) and 19.20% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,171.37 Bn 1,139.96 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 645.23 Bn 565.09 Bn 17.30 Bn 24.35%
3 AbbVie 502.25 Bn 475.37 Bn 12.70 Bn 37.86%
4 Merck 361.34 Bn 315.71 Bn 12.21 Bn -3.52%
5 Novartis Ag 302.82 Bn 266.81 Bn 11.24 Bn 32.97%
6 Astrazeneca 267.91 Bn 241.60 Bn 12.86 Bn 20.57%
7 Amgen 242.39 Bn 197.79 Bn 7.24 Bn 34.95%
8 Gilead Sciences 193.55 Bn 167.74 Bn 6.22 Bn -133.21%
9 Pfizer 172.05 Bn 118.70 Bn 10.94 Bn 28.37%
10 Evofem Biosciences 1.33 Mn 1.33 Mn 2.12 Mn -94.53%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -94.53%
Mar 31, 2026 -508.23%
Dec 31, 2025 34.99%
Sep 30, 2025 19.20%
Jun 30, 2025 -25.93%
Mar 31, 2025 38.70%
Dec 31, 2024 -14.12%
Sep 30, 2024 -54.27%
Jun 30, 2024 -33.39%
Mar 31, 2024 -78.93%
Dec 31, 2023 -69.85%
Sep 30, 2023 -69.48%
Jun 30, 2023 -298.45%
Mar 31, 2023 -61.61%
Dec 31, 2022 -6,658.56%
Sep 30, 2022 -293.89%
Jun 30, 2022 -404.69%
Mar 31, 2022 -680.52%
Dec 31, 2021 -1,048.12%
Sep 30, 2021 -2,533.24%
API Access

Evofem Biosciences Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=EVFM&period=max&api_key=YOUR_API_KEY